HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,200
-200 (-0.85%)
Dec 19, 2024, 3:00 PM KST

HLB Pharmaceutical Revenue

In the year 2019, HLB Pharmaceutical had annual revenue of 36.10B KRW with 75.75% growth. HLB Pharmaceutical had revenue of 9.89B in the quarter ending December 31, 2019, with 49.61% growth.

Revenue
36.10B
Revenue Growth
+75.75%
P/S Ratio
8.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
320.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 201936.10B15.56B75.75%
Dec 31, 201820.54B4.98B32.03%
Dec 31, 201715.56B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition